Daily non-political popular news in brief.

Fatherhood linked to prostate cancer risk

A new study from Danish researchers has found that childless men have a lower risk of developing prostate cancer than fathers, and that, paradoxically, the more children a father has, the lower the risk of the disease.

Read more »

Keywords: fatherhood, linked, prostate, cancer, risk

« Previous | Next »

Similar news on "Fatherhood linked to prostate cancer risk":

1. Heavy multivitamin use may be linked to advanced prostate cancer
   05-15-2007 · EurekAlert!
   While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced or fatal prostate cancers, according to a study in the May 16 issue of the Journal of the National Cancer Institute.
   Similar news · Read more »
   
2. Scientists discover genetic variant associated with prostate cancer in African Americans
   10-31-2007 · EurekAlert!
   Researchers report a new genetic variant that is linked to higher incidence of prostate cancer in African-American men. This study emphasizes the importance of characterizing genetic markers associated with prostate cancer in high-risk populations.
   Similar news · Read more »
   
3. Obesity and overweight linked to higher prostate cancer mortality
   11-12-2007 · EurekAlert!
   Men who are overweight or obese when diagnosed with prostate cancer are at greater risk of death after treatment.
   Similar news · Read more »
   
4. Prostate cancer therapy linked to increased risk of heart disease death
   10-09-2007 · EurekAlert!
   The use of androgen deprivation therapy to treat localized prostate cancer is associated with an increased risk of death from heart disease, according to a study published online Oct. 9 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
5. Study finds gene linked to aggressive prostate cancer
   12-11-2007 · EurekAlert!
   Results from two genome-wide association studies have identified a genetic variant of the DAB2IP gene that is associated with the risk of aggressive prostate cancer. Research teams from the Translational Genomics Research Institute, Wake Forest University School of Medicine, the Karolinska Institute in Stockholm, Sweden, and Johns Hopkins Medical Institutions made the discovery jointly.
   Similar news · Read more »
   
6. Faulty gene linked to prostate cancer risk
   10-30-2006 · EurekAlert!
   Missing sections of a gene, which programs the manufacture of a chemical to alert the body to DNA damage, almost doubles the risk of prostate cancer, reveals research published ahead of print in the Journal of Medical Genetics.
   Similar news · Read more »
   
7. Long-term use of adult-strength aspirin linked to a moderate decreased cancer risk
   04-17-2007 · EurekAlert!
   A daily dose of adult-strength aspirin may modestly reduce cancer risk in populations with high rates of colorectal, prostate, and breast cancer if taken for at least five years.
   Similar news · Read more »
   
8. Gene markers located for hereditary prostate cancer
   01-16-2008 · EurekAlert!
   Researchers at the Johns Hopkins Brady Urological Institute, Wake Forest University and the Karolinska Institute in Sweden have identified an array of gene markers for hereditary prostate cancer that, along with family history for the disease, appear to raise risk to more than nine times that of men without such markers. The panel, gleaned from a study of more than 4,000 Swedes, found that these markers are common and could account for nearly half of the prostate cancer cases in this study.
   Similar news · Read more »
   
9. Dietary folate intake not associated with breast cancer risk
   11-14-2006 · EurekAlert!
   Low dietary intake of folate was not linked to breast cancer risk, according to a systematic review in the November 15 issue of the Journal of the National Cancer Institute.
   Similar news · Read more »
   
10. PSA doubling predicts prostate cancer recurrence
    04-09-2007 · EurekAlert!
    A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. Doubling time is defined as the duration for PSA levels in the blood to increase by 100 percent.
    Similar news · Read more »